CSS
ARKG icon

Cubist Systematic Strategies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cubist Systematic Strategies’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,061
Closed -$481K – 2951
2024
Q1 		$548K Buy
+19,061
New +$573K ﹤0.01% 2558

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cubist Systematic Strategies's ARKG Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 19,061 shares — an estimated $481K sold.

Cubist Systematic Strategies first reported a position in ARKG in Q1 2024 and held it in 1 quarter. The position peaked at $548K in Q1 2024. 263 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 19,061 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $481K.
  • Cubist Systematic Strategies first reported a position in ARK Genomic Revolution ETF in Q1 2024 and held it in 1 quarter.
  • Cubist Systematic Strategies's ARK Genomic Revolution ETF position peaked at $548K in Q1 2024.
  • 263 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.